Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

12 Health Care Stocks Moving In Thursday's Intraday Session

Author: Benzinga Insights | December 15, 2022 01:32pm

Gainers

  • Scopus BioPharma (NASDAQ:SCPS) stock increased by 68.2% to $0.39 during Thursday's regular session. As of 12:30 EST, Scopus BioPharma's stock is trading at a volume of 27.2 million, which is 7181.3% of its average full-day volume over the last 100 days. The company's market cap stands at $8.3 million.
  • Icosavax (NASDAQ:ICVX) stock moved upwards by 64.57% to $14.68. Icosavax's stock is trading at a volume of 30.3 million shares as of 12:30 EST. This is 16467.0% of its average full-day volume over the last 100 days. The company's market cap stands at $585.7 million.
  • Kintara Therapeutics (NASDAQ:KTRA) stock increased by 34.76% to $10.79. Trading volume for this security as of 12:30 EST is 325.2K, which is 86.9% of its average full-day volume over the last 100 days. The company's market cap stands at $17.4 million.
  • Champions Oncology (NASDAQ:CSBR) stock increased by 23.5% to $5.68. Trading volume for this security as of 12:30 EST is 89.5K, which is 842.5% of its average full-day volume over the last 100 days. The company's market cap stands at $77.0 million. As per the news, the Q2 earnings report came out 2 days ago.
  • Soligenix (NASDAQ:SNGX) shares moved upwards by 16.64% to $0.63. As of 12:30 EST, Soligenix's stock is trading at a volume of 333.3K, which is 443.8% of its average full-day volume over the last 100 days. The company's market cap stands at $27.2 million.
  • PLx Pharma (NASDAQ:PLXP) shares moved upwards by 15.48% to $0.23. As of 12:30 EST, this security is trading at a volume of 108.8K shares, making up 37.7% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $6.8 million.

Losers

  • Third Harmonic Bio (NASDAQ:THRD) shares decreased by 78.1% to $4.34 during Thursday's regular session. Trading volume for Third Harmonic Bio's stock is 4.0 million as of 12:30 EST. This is 2811.2% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $176.1 million.
  • Axcella Health (NASDAQ:AXLA) shares declined by 30.36% to $0.62. The current volume of 375.1K shares is 208.4% of Axcella Health's average full-day volume over the last 100 days (last updated at 12:30 EST). The company's market cap stands at $45.6 million.
  • Miromatrix Medical (NASDAQ:MIRO) shares decreased by 28.66% to $2.92. The current volume of 103.1K shares is 393.5% of Miromatrix Medical's average full-day volume over the last 100 days (last updated at 12:30 EST). The company's market cap stands at $61.1 million.
  • Nexalin Technology (NASDAQ:NXL) stock fell 27.87% to $1.13. As of 12:30 EST, this security is trading at a volume of 1.8 million shares, making up 536.8% of its average full-day volume over the last 100 days. The company's market cap stands at $8.1 million.
  • Vallon Pharmaceuticals (NASDAQ:VLON) stock declined by 27.38% to $0.37. As of 12:30 EST, Vallon Pharmaceuticals's stock is trading at a volume of 5.9 million, which is 291.7% of its average full-day volume over the last 100 days. The company's market cap stands at $4.7 million.
  • Novavax (NASDAQ:NVAX) shares decreased by 26.3% to $12.7. As of 12:30 EST, Novavax's stock is trading at a volume of 19.7 million, which is 389.0% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $997.0 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: AXLA CSBR ICVX KTRA MIRO NVAX NXL PLXP SCPS SNGX THRD VLON

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist